<sup>225</sup>Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors-Reference-Cited by-同舟云学术

²²⁵Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors

Published:2022-11-17 Issue:4 Volume:64 Page:549-554
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

King A. Paden,Gutsche Nicholas T.,Raju Natarajan,Fayn Stanley,Baidoo Kwamena E.,Bell Meghan M.,Olkowski Colleen S.,Swenson Rolf E.,Lin Frank I.,Sadowski Samira M.,Adler Stephen S.,Thiele Nikki A.,Wilson Justin J.,Choyke Peter L.,Escorcia Freddy E.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference46 articles.

1. Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas

2. Global burden of neuroendocrine tumors and changing incidence in Kentucky;Chauhan;Oncotarget.,2018

3. GEP-NETs update: biotherapy for neuroendocrine tumours;Alonso-Gordoa;Eur J Endocrinol.,2015

4. Somatostatin receptor PET ligands: the next generation for clinical practice;Pauwels;Am J Nucl Med Mol Imaging.,2018

5. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical evaluation of [225Ac]Ac-crown-TATE – An alpha-emitting radiopharmaceutical for neuroendocrine tumors;Nuclear Medicine and Biology;2024-11

2. Future Treatment Strategies for Cancer Patients Combining Targeted Alpha Therapy with Pillars of Cancer Treatment: External Beam Radiation Therapy, Checkpoint Inhibition Immunotherapy, Cytostatic Chemotherapy, and Brachytherapy;Pharmaceuticals;2024-08-05

3. Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of²²⁵Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models;Journal of Nuclear Medicine;2024-07-25

4. Radiotheranostics Global Market and Future Developments;Seminars in Nuclear Medicine;2024-07

5. Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide;Medicina;2024-06-25